Discover 3,465 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,465
Duration of Urinary Catheterization
for
Colorectal Surgery
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT04359069
Recruiting
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
for
Metastatic Malignant Solid Neoplasm,
Location: Los Angeles CA, Duarte CA, La Jolla CA, San Diego CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687110
Phase1, Recruiting
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
for
Localized Prostate Carcinoma,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Male
Age: 55 - 70+
Code: NCT06500169
Recruiting
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Location: Thousand Oaks CA, Rapid City SD, San Antonio TX,
Sponsor: EmStop Inc
Sex: All
Age: 22+
Code: NCT07276711
Recruiting
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
for
Triple Negative Breast Cancer
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT05989828
Phase1, Recruiting
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized
Location: Pasadena CA, Houston TX, O'Fallon IL, Chicago IL,
Sponsor: Aurinia Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07596901
Phase1, Phase2, Recruiting
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
for
Crohn Disease
Location: Oxnard CA, Las Vegas NV, Englewood CO, San Antonio TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07483099
Phase2, Recruiting
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
for
Clonal Cytopenia of Undetermined Significance,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06063486
Phase2, Recruiting
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
for
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation,
Location: Los Angeles CA, Duarte CA, Houston TX, Madison WI,
Sponsor: National Cancer Institute (NCI)
Sex: Male
Age: 18+
Code: NCT05691465
Phase2, Recruiting
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
for
Advanced NUT Carcinoma, Metastatic NUT Carcinoma,
Location: Los Angeles CA, Houston TX, Pittsburgh PA, Boston MA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05019716
Phase1, Phase2, Recruiting
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
for
Prostate Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Male
Age: 18+
Code: NCT06067295
Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
for
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer,
Location: Los Angeles CA, San Francisco CA, Aurora CO, Seattle WA,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07066657
Phase1, Recruiting
Postpartum NSAIDS and Maternal Hypertension
for
Preeclampsia, Gestational Hypertension,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT03824119
Recruiting
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
for
Breast, Metastatic, Triple Negative, Cancer,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18 - 70+
Code: NCT04333706
Phase1, Phase2, Recruiting
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer